31 October 2022 : Clinical Research
hOGG1 rs1052133 Polymorphism and Prostate Cancer Risk: A Chinese Case-Control Study and Meta-Analysis
Hanjiang Xu123BCDEF*, Meng Zhang123BCDEF, Zongyao Hao123AC, Chaozhao Liang123ADOI: 10.12659/MSM.938012
Med Sci Monit 2022; 28:e938012
Supplementary Table 1 The NOS scores of the included eleven studies.
| Study | Selection | Comparability | Exposure/outcome | |||
|---|---|---|---|---|---|---|
| Researcher 1 | Researcher 2 | Researcher 1 | Researcher 2 | Researcher 1 | Researcher 2 | |
| Chen et al, 2003 | ||||||
| Xu et al, 2002 | ||||||
| Zhang et al, 2010 | ||||||
| Lavender et al, 2010 | ||||||
| Dhillon et al, 2011 | ||||||
| Mittal et al, 2012 | ||||||
| Yun et al, 2012 | ||||||
| Zhou et al, 2013 | ||||||
| Gong et al, 2022 | ||||||
| Xu et al, 2022 | ||||||